Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'
Br J Haematol
.
2020 Nov;191(3):505-506.
doi: 10.1111/bjh.17110.
Epub 2020 Oct 26.
Authors
Thomas A Fox
1
2
,
Ethan Troy-Barnes
1
,
Amy A Kirkwood
3
,
Wei Y Chan
1
4
,
James W Day
1
2
5
,
Selina J Chavda
1
4
,
Emil A Kumar
1
6
,
Kate David
7
,
Oliver Tomkins
1
,
Emilie Sanchez
7
,
Marie Scully
1
5
,
Asim Khwaja
1
4
,
Jonathan Lambert
1
5
,
Mervyn Singer
5
8
,
Claire Roddie
1
5
,
Emma C Morris
1
2
5
9
,
Kwee L Yong
1
4
5
,
Kirsty J Thomson
1
5
,
Kirit M Ardeshna
1
5
Affiliations
1
Department of Haematology, University College London NHS Foundation Trust, London, UK.
2
UCL Institute of Immunity and Transplantation, UCL, London, UK.
3
CR UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, UK.
4
Department of Haematology, UCL Cancer Institute, London, UK.
5
UCLH NIHR Biomedical Research Centre, London, UK.
6
Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
7
Department of Clinical Virology, University College London NHS Foundation Trust, London, UK.
8
Bloomsbury Institute of Intensive Care Medicine, UCL, London, UK.
9
Department Immunology, Royal Free London Hospitals NHS Foundation Trust, London, UK.
PMID:
33103782
DOI:
10.1111/bjh.17110
No abstract available
Publication types
Comment
MeSH terms
Betacoronavirus*
COVID-19
Coronavirus Infections*
Critical Illness*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2